SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : MGI Pharma MOGN New patents, anti cancer
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Pseudo Biologist who wrote (1250)8/12/1999 1:23:00 PM
From: Ward Knutson   of 1826
 
Pseudo, the BACKGROUND OF THE MERGER is indeed interesting.

Here is another intriguing PNU filing:
sec.gov

What we know for certain is that there are several large pharmas who have gone on record stating that they seek to grow their business through an aggressive acquisition strategy. PNU is making a significant push to strengthen its presence in oncology and the Sugen deal is certainly not the end of their quest.

Let's hope that before MGI is swept up there is some form of partnering and collaboration to significantly increase the valuation. This may well be happening behind the scenes as we type.

Rothwell conspicuously absent from the MGI Annual Shareholder's meeting...

Interesting times.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News